Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

PNPO anticorps

L’anticorps Souris Monoclonal anti-PNPO a été validé pour WB, IHC et FACS. Il convient pour détecter PNPO dans des échantillons de Humain.
N° du produit ABIN2729268

Aperçu rapide pour PNPO anticorps (ABIN2729268)

Antigène

Voir toutes PNPO Anticorps
PNPO (Pyridoxamine 5'-Phosphate Oxidase (PNPO))

Reactivité

  • 48
  • 13
  • 12
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Humain

Hôte

  • 38
  • 12
Souris

Clonalité

  • 40
  • 10
Monoclonal

Conjugué

  • 28
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Cet anticorp PNPO est non-conjugé

Application

  • 31
  • 18
  • 9
  • 5
  • 4
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Flow Cytometry (FACS)

Clone

1G9
  • Attributs du produit

    Homo sapiens pyridoxamine 5'-phosphate oxidase (PNPO)

    Purification

    Purified from mouse ascites fluids by affinity chromatography

    Immunogène

    Full length human recombinant protein of human PNPO(NP_060599) produced in HEK293T cell.

    Isotype

    IgG2a
  • Indications d'application

    WB 1:4000, IHC 1:150, FLOW 1:100,

    Commentaires

    The concentration of the product may vary between diferrent lots.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    0.5-1.0 mg/mL

    Buffer

    PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C
  • Antigène

    PNPO (Pyridoxamine 5'-Phosphate Oxidase (PNPO))

    Autre désignation

    PNPO

    Sujet

    The enzyme encoded by this gene catalyzes the terminal, rate-limiting step in the synthesis of pyridoxal 5'-phosphate, also known as vitamin B6. Vitamin B6 is a required co-factor for enzymes involved in both homocysteine metabolism and synthesis of neurotransmitters such as catecholamine. Mutations in this gene result in pyridoxamine 5'-phosphate oxidase (PNPO) deficiency, a form of neonatal epileptic encephalopathy. COMPLETENESS: complete on the 3' end.

    Poids moléculaire

    29.8 kDa

    ID gène

    55163

    NCBI Accession

    NM_018129

    HGNC

    55163
Vous êtes ici:
Chat with us!